Dendreon Company Profile (NASDAQ:DNDN)

About Dendreon (NASDAQ:DNDN)

Dendreon logoDendreon Corporation, is a biotechnology company. The Company is focused on discovery, development and commercialization of therapeutics for cancer treatment. The Company's product portfolio includes cellular immunotherapies and small molecule product candidate that could be applicable to treating multiple types of cancers. The Company's product PROVENGE (sipuleucel-T), is an autologous cellular immunotherapy for the treatment of asymptomatic and minimally symptomatic, metastatic, castrate-resistant hormone-refractory prostate cancer. Other potential product candidates include investigational active cellular immunotherapy, which potentially may be used for the treatment of patients with bladder, breast, ovarian and other solid tumors expressing HER2/neu; active cellular immunotherapies directed at carbonic anhydrase 9, an antigen highly expressed in renal cell carcinoma, and carcinoembryonic antigen, an antigen expressed in colorectal and other cancers.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:DNDN
  • CUSIP: 24823Q10
  • Web: www.dendreon.com/
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.32
  • P/E Growth: N/A
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: -30.18%
  • Return on Assets: -25.12%
 

Frequently Asked Questions for Dendreon (NASDAQ:DNDN)

What is Dendreon's stock symbol?

Dendreon trades on the NASDAQ under the ticker symbol "DNDN."

How were Dendreon's earnings last quarter?

Dendreon Co. (NASDAQ:DNDN) announced its quarterly earnings data on Monday, November, 10th. The company reported ($0.14) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.04. The firm had revenue of $73.10 million for the quarter, compared to analyst estimates of $78.72 million. The company's quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter last year, the firm earned ($0.44) EPS. View Dendreon's Earnings History.

Who are some of Dendreon's key competitors?

How do I buy Dendreon stock?

Shares of Dendreon can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dendreon's stock price today?

One share of Dendreon stock can currently be purchased for approximately $0.13.


MarketBeat Community Rating for Dendreon (NASDAQ DNDN)
Community Ranking:  1.1 out of 5 (star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  359 (Vote Underperform)
Total Votes:  461
MarketBeat's community ratings are surveys of what our community members think about Dendreon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Dendreon (NASDAQ:DNDN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Dendreon (NASDAQ:DNDN)
Price Target History for Dendreon (NASDAQ:DNDN)
Analysts' Ratings History for Dendreon (NASDAQ:DNDN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Dendreon (NASDAQ:DNDN)
Earnings by Quarter for Dendreon (NASDAQ:DNDN)
Earnings History by Quarter for Dendreon (NASDAQ DNDN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2014Q3($0.10)($0.14)$78.72 million$73.10 millionViewN/AView Earnings Details
8/20/2014($0.18)($0.18)ViewN/AView Earnings Details
8/11/2014($0.25)($0.10)$73.37 million$82.16 millionViewN/AView Earnings Details
5/8/2014Q114($0.28)($0.24)$69.19 million$68.70 millionViewListenView Earnings Details
3/3/2014Q413($0.37)($0.17)$73.59 million$74.80 millionViewListenView Earnings Details
11/12/2013Q313($0.42)($0.44)$76.60 million$68.00 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.42)($0.45)$75.61 million$73.30 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.47)($0.48)$80.15 million$67.60 millionViewN/AView Earnings Details
2/25/2013Q4 2012($0.56)($0.26)$82.88 million$85.49 millionViewN/AView Earnings Details
11/2/2012Q312($0.75)($0.33)$80.68 million$78.00 millionViewN/AView Earnings Details
5/2/2011($0.70)($0.77)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dendreon (NASDAQ:DNDN)
Current Year EPS Consensus Estimate: $-0.730 EPS
Next Year EPS Consensus Estimate: $-0.400 EPS

Dividends

Dividend History for Dendreon (NASDAQ:DNDN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dendreon (NASDAQ:DNDN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Dendreon (NASDAQ:DNDN)
Latest Headlines for Dendreon (NASDAQ:DNDN)
Source:

Social

Chart

Dendreon (DNDN) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.